Publisher Correction: Continuous evolution of base editors with expanded target compatibility and improved activity

B W Thuronyi^{1

2

3}, Luke W Koblan^#^{1

2}, Jonathan M Levy^#^{1

2}, Wei-Hsi Yeh^{1

2

4}, Christine Zheng², Gregory A Newby^{1

2}, Christopher Wilson^{1

2}, Mantu Bhaumik⁵, Olga Shubina-Oleinik⁶, Jeffrey R Holt⁶, David R Liu^{7

8

9}

Affiliations

¹ Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
² Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
³ Department of Chemistry, Williams College, Williamstown, MA, USA.
⁴ Program in Speech and Hearing Bioscience and Technology, Harvard Medical School, Boston, MA, USA.
⁵ Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
⁶ Departments of Otolaryngology and Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
⁷ Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA. drliu@fas.harvard.edu.
⁸ Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.
⁹ Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.

^# Contributed equally.

Published Erratum

B W Thuronyi et al. Nat Biotechnol. 2019 Sep.

. 2019 Sep;37(9):1091.

doi: 10.1038/s41587-019-0253-5.

¹ Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
² Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
³ Department of Chemistry, Williams College, Williamstown, MA, USA.
⁴ Program in Speech and Hearing Bioscience and Technology, Harvard Medical School, Boston, MA, USA.
⁵ Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
⁶ Departments of Otolaryngology and Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
⁷ Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA. drliu@fas.harvard.edu.
⁸ Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.
⁹ Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA. drliu@fas.harvard.edu.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Continuous evolution of base editors with expanded target compatibility and improved activity.
Thuronyi BW, Koblan LW, Levy JM, Yeh WH, Zheng C, Newby GA, Wilson C, Bhaumik M, Shubina-Oleinik O, Holt JR, Liu DR. Thuronyi BW, et al. Nat Biotechnol. 2019 Sep;37(9):1070-1079. doi: 10.1038/s41587-019-0193-0. Epub 2019 Jul 22. Nat Biotechnol. 2019. PMID: 31332326 Free PMC article.